Familial Alzheimer's disease associated with heterozygous NPC1 mutation

被引:0
|
作者
Lopergolo, Diego [1 ,2 ]
Bianchi, Silvia [1 ,2 ]
Gallus, Gian Nicola [1 ,2 ]
Locci, Sara [1 ,2 ]
Pucci, Barbara [1 ,3 ]
Leoni, Valerio [4 ]
Gasparini, Daniele [1 ,2 ]
Tardelli, Elisa [5 ]
Chincarini, Andrea [6 ]
Sestini, Stelvio [5 ]
Santorelli, Filippo Maria [7 ]
Zetterberg, Henrik [8 ,9 ,10 ,11 ,12 ]
De Stefano, Nicola [1 ,2 ]
Mignarri, Andrea [1 ,2 ,13 ]
机构
[1] Univ Siena, Dept Med Surg & Neurosci, Siena, Italy
[2] Azienda Osped Univ Senese, UOC Neurol & Malattie Neurometab, Siena, Italy
[3] Azienda Osped Univ Senese, UOC Neurol & Neurofisiol Clin, Siena, Italy
[4] Univ Milano Bicocca, Hosp Desio, ASST Brianza, Lab Clin Chem,Sch Med & Surg, Milan, Italy
[5] Azienda USL Toscana Ctr, Dept Diagnost Imaging, Unit Nucl Med, PO S Stefano, Prato, Italy
[6] Natl Inst Nucl Phys INFN, Genoa, Italy
[7] IRCCS Stella Maris Fdn, Mol Med Neurodegenerat & Neuromuscular Dis Unit, Calambrone, Italy
[8] Univ Gothenburg, Inst Neurosci & Physiol, Sahlgrenska Acad, Gothenburg, Sweden
[9] Sahlgrens Univ Hosp, Clin Neurochem Lab, Molndal, Sweden
[10] UCL, UK Dementia Res Inst, London, England
[11] UCL, Dept Neurodegenerat Dis, Inst Neurol, London, England
[12] Hong Kong Ctr Neurodegenerat Dis, Hong Kong, Peoples R China
[13] Univ Siena, Dept Med Surg & Neurosci, I-53100 Siena, Italy
基金
欧洲研究理事会; 欧盟地平线“2020”;
关键词
brain diseases; metabolic; central nervous system diseases; neurodegenerative diseases; dementia; NIEMANN-PICK-DISEASE; RAPID DIAGNOSIS; 7-KETOCHOLESTEROL; PLASMA; METABOLISM; DISORDERS; RISK;
D O I
10.1136/jmg-2023-109219
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Introduction NPC1 mutations are responsible for Niemann-Pick disease type C (NPC), a rare autosomal recessive neurodegenerative disease. Patients harbouring heterozygous NPC1 mutations may rarely show parkinsonism or dementia. Here, we describe for the first time a large family with an apparently autosomal dominant late-onset Alzheimer's disease (AD) harbouring a novel heterozygous NPC1 mutation.Methods All the five living siblings belonging to the family were evaluated. We performed clinical evaluation, neuropsychological tests, assessment of cerebrospinal fluid markers of amyloid deposition, tau pathology and neurodegeneration (ATN), structural neuroimaging and brain amyloid-positron emission tomography. Oxysterol serum levels were also tested. A wide next-generation sequencing panel of genes associated with neurodegenerative diseases and a whole exome sequencing analysis were performed.Results We detected the novel heterozygous c.3034G>T (p.Gly1012Cys) mutation in NPC1, shared by all the siblings. No other point mutations or deletions in NPC1 or NPC2 were found. In four siblings, a diagnosis of late-onset AD was defined according to clinical characterisation and ATN biomarkers (A+, T+, N+) and serum oxysterol analysis showed increased 7-ketocholesterol and cholestane-3 beta,5 alpha,6 beta-triol.Discussion We describe a novel NPC1 heterozygous mutation harboured by different members of a family with autosomal dominant late-onset amnesic AD without NPC-associated features. A missense mutation in homozygous state in the same aminoacidic position has been previously reported in a patient with NPC with severe phenotype. The alteration of serum oxysterols in our family corroborates the pathogenic role of our NPC1 mutation. Our work, illustrating clinical and biochemical disease hallmarks associated with NPC1 heterozygosity in patients affected by AD, provides relevant insights into the pathogenetic mechanisms underlying this possible novel association.
引用
收藏
页码:332 / 339
页数:8
相关论文
共 50 条
  • [31] Familial Alzheimer's disease in Israel associated with an S182 codon 286 mutation on chromosome 14
    Chapman, J
    Asherov, A
    Treves, TA
    Wang, NS
    Korczyn, AD
    Goldfarb, LG
    NEUROLOGY, 1996, 46 (02) : 2063 - 2063
  • [32] Niemann-Pick C1 (NPC1)/NPC1-like1 Chimeras Define Sequences Critical for NPC1's Function as a Filovirus Entry Receptor
    Krishnan, Anuja
    Miller, Emily Happy
    Herbert, Andrew S.
    Ng, Melinda
    Ndungo, Esther
    Whelan, Sean P.
    Dye, John M.
    Chandran, Kartik
    VIRUSES-BASEL, 2012, 4 (11): : 2471 - 2484
  • [33] Very early-onset familial Alzheimer's disease: a novel presenilin 1 mutation
    Goldman, JS
    Reed, B
    Gearhart, R
    Kramer, JH
    Miller, BL
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2002, 17 (07) : 649 - 651
  • [34] Familial Alzheimer’s Disease due to Presenilin 1 Mutation at the Age of 33: a Case Report
    Rita Raimundo
    Rafael Jesus
    Andreia Veiga
    SN Comprehensive Clinical Medicine, 2021, 3 (10) : 2021 - 2023
  • [35] PEN–2 gene mutation in a familial Alzheimer’s disease case
    C. Sala Frigerio*
    P. Piscopo*
    E. Calabrese
    A. Crestini
    L. Malvezzi Campeggi
    R. Civita di Fava
    S. Fogliarino
    D. Albani
    G. Marcon
    R. Cherchi
    R. Piras
    G. Forloni
    A. Confaloni
    Journal of Neurology, 2005, 252 : 1033 - 1036
  • [36] A novel presenilin 1 mutation (L282F) in familial Alzheimer’s disease
    Tsuyoshi Hamaguchi
    Akiyoshi Morinaga
    Tamao Tsukie
    Ryozo Kuwano
    Masahito Yamada
    Journal of Neurology, 2009, 256 : 1575 - 1577
  • [37] A novel presenilin 1 mutation (L282F) in familial Alzheimer's disease
    Hamaguchi, Tsuyoshi
    Morinaga, Akiyoshi
    Tsukie, Tamao
    Kuwano, Ryozo
    Yamada, Masahito
    JOURNAL OF NEUROLOGY, 2009, 256 (09) : 1575 - 1577
  • [38] Familial Alzheimer's disease: Site of mutation influences clinical phenotype
    Lippa, CF
    Swearer, JM
    Kane, KJ
    Nochlin, D
    Bird, TD
    Ghetti, B
    Nee, LE
    St George-Hyslop, P
    Pollen, DA
    Drachman, DA
    ANNALS OF NEUROLOGY, 2000, 48 (03) : 376 - 379
  • [39] A novel mutation in the chromosome 14 familial Alzheimer's disease gene
    Isla, TG
    Wasco, W
    Pettingell, WP
    Jondro, PD
    Schmidt, SD
    Gurubhagavatula, S
    Rodes, L
    Romano, DM
    Guenette, SY
    Kovacs, DM
    Growdon, JH
    Hyman, BT
    Tanzi, RE
    NEUROLOGY, 1996, 46 (02) : 3077 - 3077
  • [40] Decreased Npc1 Gene Dosage in Mice Is Associated With Weight Gain
    Jelinek, David
    Heidenreich, Randall A.
    Erickson, Robert P.
    Garver, William S.
    OBESITY, 2010, 18 (07) : 1457 - 1459